Drew J Fromkin Insider Trading
Get free email notifications about insider trading for Drew J Fromkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Drew J Fromkin. Drew J Fromkin is a EVP and Chief Marketing Off. in CLINICAL DATA INC ($NOVI) and a Director in Tobira Therapeutics, Inc. ($TBRA) and a Director in Health Sciences Acquisitions Corp ($HSAC).
Address: C/O CLINICAL DATA, INC. ONE GATEWAY CENTER, SUITE 411 NEWTON 02458 MA
Companies in which Drew J Fromkin is an Insider
CLINICAL DATA INC
Trading Symbol: NOVIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Drew J Fromkin: EVP and Chief Marketing Off.
Holdings: 0 shares
Latest Transaction: Oct 19 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Immunovant, Inc.
Trading Symbol: IMVTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Drew J Fromkin: Director
Holdings: 40,200 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tobira Therapeutics, Inc.
Trading Symbol: TBRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Drew J Fromkin: Director
Holdings: 0 shares
Latest Transaction: Nov 03 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Drew J Fromkin
Sentiment: All, NOVI, IMVT, TBRA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 |